Losan Pharma

Losan Pharma is an established, privately-held CDMO based in Neuenburg, Germany, serving the global pharmaceutical market. The company leverages its expertise in drug delivery and formulation to enhance the performance of active pharmaceutical ingredients (APIs) for its clients. Its core business is providing contract development and manufacturing services, with a proven track record of regulatory compliance, including successful FDA and international inspections. Losan is currently expanding its infrastructure with new production and logistics facilities, underscoring its growth trajectory and commitment to operational excellence.

Formulation science and drug delivery platform focused on improving API performance through enhanced stability, bioavailability, and customized release profiles for solid, semi-solid, and liquid dosage forms.

Losan Pharma competes in the fragmented but growing global CDMO market. It faces competition from large, multinational CDMOs (e.g., Lonza, Catalent) with broader service offerings and greater resources, as well as from smaller, niche players and lower-cost providers in Asia and Eastern Europe. Its differentiation lies in its deep expertise in formulation problem-solving for small molecules, a full-service offering from development to commercial packaging, and a strong regulatory standing in key international markets.